Glasgow, United Kingdom

ESTRO 2024

Local time in host city

Programme

10 Sessions
Sunday
May 05
10:30 - 11:30
Carron 2
Jose Belderbos, The Netherlands;
Valeria Dionisi, Italy
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be recorded.
Mini-Oral
Clinical
Sunday
May 05
10:30 - 11:30
Dochart 1
Navita Somaiah, United Kingdom
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.
Poster Discussion
Radiobiology
Sunday
May 05
10:30 - 11:30
Dochart 2
Youlia Kirova, France
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.
Poster Discussion
Clinical
Sunday
May 05
11:40 - 12:40
Armadillo
Coen Hurkmans, The Netherlands;
Monica Buijs, The Netherlands
This session will celebrate the best abstract submitted to each track. Join us in congratulating the winners during this plenary session and listen to the top-level presentations.
Proffered Papers
Interdisciplinary
Sunday
May 05
11:40 - 12:40
M1
Ursula Nestle, Germany
Multidisciplinary Tumour Board
Clinical
Sunday
May 05
13:00 - 14:40
Hall 3
Catharine Clark, United Kingdom
Assembly
Physics
Sunday
May 05
14:15 - 14:40
Armadillo
Award Lecture
Interdisciplinary
Sunday
May 05
14:45 - 16:00
Hall 2
Anna Kirby, United Kingdom;
Jeff Michalski, USA
Joint Symposium
Interdisciplinary
Sunday
May 05
14:45 - 16:00
Boisdale
Jacopo Iacovacci, Italy;
Monica Mangoni, Italy
How will microbiota and metabolic regulation change the management of cancer patients? Altered metabolism is an important feature of cancer cells and a driving force for malignant progression. In cancer cells, metabolism is dysregulated to support the demands of uncontrolled proliferation. Furthermore, microorganisms within the gut and other niches play an intricate role in the metabolic regulation of host processes at the cellular and systemic levels., that can be rapidly altered by changes to the diet. Metabolic alterations in cancer therapy are key determinants to therapeutic toxicities and responses. Better knowledge on how metabolism and cancer interact and on the metabolic interplay at the host-microbe interface can help to develop novel therapeutic strategies to improve treatment outcomes in cancer.
Symposium
Radiobiology
Sunday
May 05
14:45 - 16:00
Armadillo
Ben Slotman, The Netherlands;
Joe Chang, USA
Joint Symposium
Clinical
+(event:"415f9a23-87eb-ed11-8849-000d3adea44c")